Oscar Health, Inc.
HealthcareNYSE:OSCR · New York Stock Exchange
-$0.65 today
Vol 5.76M · Avg 7.39M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-45.3%
avg -18.1%
ROIC
-27.1%
avg -16.1%
ROA
-7.0%
avg -11.7%
Analysis
ROA is currently the strongest return metric at -7.0% versus its period average of -11.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Janet Ann Liang | EVP & President of Oscar Insurance | $3.96M | — | 58 | $262,592.00 | 0.10% |
Mario Tobias Schlosser | Co-Founder, Advisor to the CEO & Director | $1.17M | — | 47 | $490,534.00 | 0.19% |
Adam McAnaney | EVP & Chief Legal Officer | $1.16M | — | 49 | $220,890.00 | 0.09% |
Mark Thomas Bertolini | Chief Executive Officer & Director | $1.15M | — | 69 | $9.20M | 3.55% |
Richard Scott Blackley | Chief Financial Officer | $1.07M | — | 58 | $1.08M | 0.42% |
Joel I. Klein | Senior Advisor | $575,000.00 | — | 79 | $17.00 | <0.01% |
Jesse Horowitz | Senior Vice President of Member Experience | — | — | — | — | — |
Rebecca Krouse | Chief People Officer | — | — | — | — | — |
Victoria Baltrus | Chief Accounting Officer | — | — | 56 | $215,021.00 | 0.08% |
Steven Kelmar | Executive VP & Chief of Staff to the CEO | — | — | 72 | $102,951.00 | 0.04% |
Chelsea Cooper | Chief Growth Officer of +Oscar | — | — | — | — | — |
Chris Potochar | Vice President of Treasury & Investor Relations | — | — | — | — | — |
Okiki Louis | President of Oscar Medical Group | — | — | — | — | — |
Joshua Kushner | Co-Founder & Vice Chairman | — | — | 41 | $6.34M | 2.45% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$11.92M
Sells
31
$28.19M
Net Sentiment
$16.27M
Net selling
Most Active
Schlosser Mario
12 transactions
1–10 of 32
Analysis
Insiders reported 1 buys worth $11.92M and 31 sells worth $28.19M over the last 12 months. That adds up to net selling of $16.27M. Schlosser Mario was the most active insider with 12 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +115.0% | +25.2% (7yr)3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | N/A3 analysts |
Analysis
Recent growth has been strongest in Revenue at +115.0% over three years. Forward estimates point to Revenue at +25.2% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.09B
Immunovant, Inc.
NASDAQ:IMVT
$6.90B
Arcellx, Inc.
ACLX
$6.73B
Hinge Health, Inc.
NYSE:HNGE
$5.06B
Akero Therapeutics, Inc.
AKRO
$4.50B
Alignment Healthcare, Inc.
NASDAQ:ALHC
$4.08B
NewAmsterdam Pharma Company N.V.
NASDAQ:NAMS
$3.55B
Viking Therapeutics, Inc.
NASDAQ:VKTX
$3.34B
Option Care Health, Inc.
NASDAQ:OPCH
$3.26B
TransMedics Group, Inc.
NASDAQ:TMDX
$2.52B
Who manages OSCR?
Oscar Health, Inc. (OSCR) lists 14 active executives. The top listed executive is Adam McAnaney, EVP & Chief Legal Officer.
Are OSCR insiders buying or selling?
Recent insider activity shows net buying of $9.59M.
Explore More
Continue the stock analysis
Jump to another research area for this company.